Minimum information about a bioactive entity (MIABE)

作者：Orchard Sandra^*; Al Lazikani Bissan; Bryant Steve; Clark Dominic; Calder Elizabeth; Dix Ian; Engkvist Ola; Forster Mark; Gaulton Anna; Gilson Michael; Glen Robert; Grigorov Martin; Hammond Kosack Kim; Harland Lee; Hopkins Andrew; Larminie Christopher; Lynch Nick; Mann Romeena K; Murray Rust Peter; Lo Piparo Elena; Southan Christopher; Steinbeck Christoph; Wishart David; Hermjakob Henning; Overington John; Thornton Janet

来源：Nature Reviews Drug Discovery, 2011, 10(9): 661-669.

DOI：10.1038/nrd3503

Bioactive molecules such as drugs, pesticides and food additives are produced in large numbers by many commercial and academic groups around the world. Enormous quantities of data are generated on the biological properties and quality of these molecules. Access to such data - both on licensed and commercially available compounds, and also on those that fail during development - is crucial for understanding how improved molecules could be developed. For example, computational analysis of aggregated data on molecules that are investigated in drug discovery programmes has led to a greater understanding of the properties of successful drugs. However, the information required to perform these analyses is rarely published, and when it is made available it is often missing crucial data or is in a format that is inappropriate for efficient data-mining. Here, we propose a solution: the definition of reporting guidelines for bioactive entities - the Minimum Information About a Bioactive Entity (MIABE) - which has been developed by representatives of pharmaceutical companies, data resource providers and academic groups.

• 出版日期2011-9